BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26647820)

  • 21. Expression of human telomerase reverse transcriptase mediates the senescence of mesenchymal stem cells through the PI3K/AKT signaling pathway.
    Zhao Q; Wang XY; Yu XX; Zhai YX; He X; Wu S; Shi YA
    Int J Mol Med; 2015 Sep; 36(3):857-64. PubMed ID: 26178664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel anticancer therapeutics targeting telomerase.
    Ruden M; Puri N
    Cancer Treat Rev; 2013 Aug; 39(5):444-56. PubMed ID: 22841437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
    Wadhwa R; Takano S; Taira K; Kaul SC
    J Gene Med; 2004 Apr; 6(4):439-44. PubMed ID: 15079818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes.
    Pellegrini G; Dellambra E; Paterna P; Golisano O; Traverso CE; Rama P; Lacal P; De Luca M
    Eur J Cell Biol; 2004 Dec; 83(11-12):691-700. PubMed ID: 15679113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells.
    Ozturk N; Erdal E; Mumcuoglu M; Akcali KC; Yalcin O; Senturk S; Arslan-Ergul A; Gur B; Yulug I; Cetin-Atalay R; Yakicier C; Yagci T; Tez M; Ozturk M
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2178-83. PubMed ID: 16461895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression.
    Torella D; Rota M; Nurzynska D; Musso E; Monsen A; Shiraishi I; Zias E; Walsh K; Rosenzweig A; Sussman MA; Urbanek K; Nadal-Ginard B; Kajstura J; Anversa P; Leri A
    Circ Res; 2004 Mar; 94(4):514-24. PubMed ID: 14726476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The disparity between human cell senescence in vitro and lifelong replication in vivo.
    Rubin H
    Nat Biotechnol; 2002 Jul; 20(7):675-81. PubMed ID: 12089551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Telomere shortening and cell senescence induced by perylene derivatives in A549 human lung cancer cells.
    Taka T; Huang L; Wongnoppavich A; Tam-Chang SW; Lee TR; Tuntiwechapikul W
    Bioorg Med Chem; 2013 Feb; 21(4):883-90. PubMed ID: 23321015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and epigenetic modulation of telomerase activity in development and disease.
    Liu L; Lai S; Andrews LG; Tollefsbol TO
    Gene; 2004 Sep; 340(1):1-10. PubMed ID: 15556289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What has senescence got to do with cancer?
    Dimri GP
    Cancer Cell; 2005 Jun; 7(6):505-12. PubMed ID: 15950900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Historical claims and current interpretations of replicative aging.
    Wright WE; Shay JW
    Nat Biotechnol; 2002 Jul; 20(7):682-8. PubMed ID: 12089552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies.
    Li Y; Tergaonkar V
    Cancer Res; 2014 Mar; 74(6):1639-44. PubMed ID: 24599132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-34a induces cellular senescence via modulation of telomerase activity in human hepatocellular carcinoma by targeting FoxM1/c-Myc pathway.
    Xu X; Chen W; Miao R; Zhou Y; Wang Z; Zhang L; Wan Y; Dong Y; Qu K; Liu C
    Oncotarget; 2015 Feb; 6(6):3988-4004. PubMed ID: 25686834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple pathways for the regulation of telomerase activity.
    Holt SE; Wright WE; Shay JW
    Eur J Cancer; 1997 Apr; 33(5):761-6. PubMed ID: 9282114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cellar senescence and tumor].
    Zhao NX; Lu SX
    Ai Zheng; 2004 Oct; 23(10):1225-30. PubMed ID: 15473942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of telomerase modulation in human hematopoietic progenitor cells.
    Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingmüller U; Martens UM
    Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient inhibition of human telomerase reverse transcriptase expression by RNA interference sensitizes cancer cells to ionizing radiation and chemotherapy.
    Nakamura M; Masutomi K; Kyo S; Hashimoto M; Maida Y; Kanaya T; Tanaka M; Hahn WC; Inoue M
    Hum Gene Ther; 2005 Jul; 16(7):859-68. PubMed ID: 16000067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PinX1: structure, regulation and its functions in cancer.
    Li HL; Song J; Yong HM; Hou PF; Chen YS; Song WB; Bai J; Zheng JN
    Oncotarget; 2016 Oct; 7(40):66267-66275. PubMed ID: 27556185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive loss of malignant behavior in telomerase-negative tumorigenic adrenocortical cells and restoration of tumorigenicity by human telomerase reverse transcriptase.
    Sun B; Huang Q; Liu S; Chen M; Hawks CL; Wang L; Zhang C; Hornsby PJ
    Cancer Res; 2004 Sep; 64(17):6144-51. PubMed ID: 15342398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.